FDA grants full approval to Pfizer's COVID-19 vaccine

FDA grants full approval to Pfizer's COVID-19 vaccine The Food and Drug Administration (FDA) granted the Pfizer-BioNTech COVID-19 vaccine full approval in a highly anticipated move that’s expected to boost vaccinations and spark more mandates Justine Coleman TheHill

The Food and Drug Administration (FDA) granted the Pfizer-BioNTech COVID-19 vaccine full approval in a highly anticipated move that’s expected to boost vaccinations and spark more mandates nationwide.

The federal agency reached the milestone of issuing the first complete authorization for a COVID-19 vaccine after an approximately three-month review of Pfizer’s and its German partner BioNTech’s application to the FDA for full approval.

With slightly more than half of the total U.S. population fully vaccinated, experts and Biden administration officials are hopeful the agency’s full approval will serve as a catalyst for vaccinations in the country.

The Pfizer-BioNTech vaccine, like the other two available in the U.S., had been given emergency use authorization allowing it to be administered only during the public health emergency. But under the full authorization, the FDA is giving permission for patients to get the shots once the public health emergency is declared over. ...